Developers of antibody tests for SARS-CoV-2 now must seek Emergency Use Authorization for their tests from the US Food and Drug Administration, as GenomeWeb reports.
Developers of antibody tests for SARS-CoV-2 now must seek Emergency Use Authorization for their tests from the US Food and Drug Administration, as GenomeWeb reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.